eng Oriental Scientific Publishing Company Biomedical and Pharmacology Journal 0974-6242 2020-12-30 13 4 2015 2024 10.13005/bpj/2080 36261 article Vishal Trivedi 1 Kush Biswas 2 Santosh Fattepur 3 Nagaraja Sreeharsha 4,5 1Department of Pharmacy, Madhav University, Abu Road, Pindwara, Rajasthan, India 2Department of Pharmaceutical technology (Biotechnology), National institute of Pharmaceutical Education and Research, Mohali, sector 67, SAS Nagar, Punjab, India 3School of Pharmacy, Management and Science University,Seksyen 13, 40100 Shah Alam, Selangor, Malaysia 4Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa-31982, Saudi Arabia. 5Department of Pharmaceutics, Vidya Siri College of Pharmacy, Off Sarjapura Road, Bengaluru - 560 035, Karnataka, India In Present time Novel coronavirus (SAR-CoV-2) was the biggest outbreak on human kind. SARS recognized febrile respiratory illness. It was first discovered in southern China in November 2002, and spread all other countries.Now SARS-CoV-2 was also originated from Wuhan, china. It was transmitted from human to human. For developing a molecular diagnostic for 2019-nCoV a PCR detection assay was developed. Sanger, Illumina, and Oxford nanopore techniques are used for sequencing analysis for 2019-nCoV.Based on different types of data base it was concluded that the SARS-CoV-2 was less mutated than other seasonal flu. This study shows the complete genome sequence and characteristic of SAR-CoV-2. SAR-CoV-2 has 29,903 nucleotides in length which is quite similar to others coronavirus. A complete genome sequence of different-different countries was studied. https://biomedpharmajournal.org/vol13no4/study-on-genome-sequence-of-novel-coronavirus-sars-cov-2-strains-in-different-countries/ Coronavirus (SAR-Cov-2)  Complete Genome Sequencing And Characterizations  PCR Detection